Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
| Sales | 825 | 1,444 | 815 | 680 | 768 |
| Gross Profit | 825 | 1,417 | 815 | 680 | 768 |
| Operating Expenses | 4,851 | 5,198 | 3,273 | 2,996 | 2,093 |
| Operating Income | -4,026 | -3,754 | -2,458 | -2,315 | -1,325 |
| Interest Expense | 0 | 137 | 0 | 0 | -13 |
| Other Income | 81 | 171 | -2,344 | -38 | 0 |
| Pre-tax Income | -3,945 | -3,720 | -4,801 | -2,354 | -1,312 |
| Net Income Continuous | -3,945 | -3,720 | -4,801 | -2,354 | -1,312 |
| Minority Interests | -583 | -753 | -130 | -94 | -25 |
| Net Income | $-3,362 | $-2,967 | $-4,671 | $-2,260 | $-1,287 |
| EPS Basic Total Ops | -0.07 | -0.07 | -0.11 | -0.06 | -0.04 |
| EPS Basic Continuous Ops | -0.08 | -0.09 | -0.11 | -0.06 | -0.04 |
| EPS Diluted Total Ops | -0.07 | -0.07 | -0.11 | -0.06 | -0.04 |
| EPS Diluted Continuous Ops | -0.08 | -0.09 | -0.11 | -0.06 | -0.04 |
| EBITDA(a) | $-3,319 | $-2,718 | $-2,065 | $-2,240 | $-1,390 |